BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22366027)

  • 1. Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus.
    Graham SP; Haines FJ; Johns HL; Sosan O; La Rocca SA; Lamp B; Rümenapf T; Everett HE; Crooke HR
    Vaccine; 2012 Apr; 30(17):2742-8. PubMed ID: 22366027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of virus-specific peripheral blood cell cytokine responses following vaccination or infection with classical swine fever viruses.
    Graham SP; Everett HE; Johns HL; Haines FJ; La Rocca SA; Khatri M; Wright IK; Drew T; Crooke HR
    Vet Microbiol; 2010 Apr; 142(1-2):34-40. PubMed ID: 19854006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo.
    Rau H; Revets H; Balmelli C; McCullough KC; Summerfield A
    Vet Res; 2006; 37(1):155-68. PubMed ID: 16336932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
    Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of cytokine production and CD25 expression by porcine lymphocyte subpopulations following exposure to classical swine fever virus (CSFV).
    Suradhat S; Sada W; Buranapraditkun S; Damrongwatanapokin S
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):197-208. PubMed ID: 15963818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus.
    Piriou L; Chevallier S; Hutet E; Charley B; Le Potier MF; Albina E
    Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.
    Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell factor-4 and MHC upregulation in pigs receiving a live attenuated classical swine fever virus (CSFV) vaccine strain with interferon-gamma adjuvant.
    Fan YH; Lin YL; Hwang YC; Yang HC; Chiu HC; Chiou SH; Jong MH; Chow KC; Lin CC
    Vet J; 2016 Oct; 216():148-56. PubMed ID: 27687943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection.
    Suradhat S; Intrakamhaeng M; Damrongwatanapokin S
    Vet Immunol Immunopathol; 2001 Dec; 83(3-4):177-89. PubMed ID: 11730928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A T-cell epitope on NS3 non-structural protein enhances the B and T cell responses elicited by dendrimeric constructions against CSFV in domestic pigs.
    Tarradas J; Monsó M; Fraile L; de la Torre BG; Muñoz M; Rosell R; Riquelme C; Pérez LJ; Nofrarías M; Domingo M; Sobrino F; Andreu D; Ganges L
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):36-46. PubMed ID: 22959286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
    Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
    Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.
    Frey CF; Bauhofer O; Ruggli N; Summerfield A; Hofmann MA; Tratschin JD
    Vet Res; 2006; 37(5):655-70. PubMed ID: 16777037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
    Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ
    Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
    Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
    Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals.
    Kortekaas J; Vloet RP; Weerdmeester K; Ketelaar J; van Eijk M; Loeffen WL
    J Virol Methods; 2010 Feb; 163(2):175-85. PubMed ID: 19770004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.